Cargando…

Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy

OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Tae Yong, Na, Young Chul, Lee, Won Hee, Kim, Ji Hee, Chang, Won Seok, Jung, Hyun Ho, Chang, Jong Hee, Chang, Jin Woo, Park, Young Gou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027101/
https://www.ncbi.nlm.nih.gov/pubmed/24904896
http://dx.doi.org/10.14791/btrt.2013.1.2.78
_version_ 1782316949792882688
author Park, Tae Yong
Na, Young Chul
Lee, Won Hee
Kim, Ji Hee
Chang, Won Seok
Jung, Hyun Ho
Chang, Jong Hee
Chang, Jin Woo
Park, Young Gou
author_facet Park, Tae Yong
Na, Young Chul
Lee, Won Hee
Kim, Ji Hee
Chang, Won Seok
Jung, Hyun Ho
Chang, Jong Hee
Chang, Jin Woo
Park, Young Gou
author_sort Park, Tae Yong
collection PubMed
description OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamma knife radiosurgery or surgical intervention for these patients. METHODS: We retrospectively reviewed the medical records and imaging data of 59 patients with metastatic brain tumors from hepatocellular carcinoma from May 2004 to September 2012. The study included patients with available clinical and radiological data who had been diagnosed with metastatic hepatocellular carcinoma of the brain, confirmed by magnetic resonance imaging. The overall survival time was analyzed and compared according to each risk factor. RESULTS: The mean age at diagnosis of metastatic brain tumor was 52.2 years (14-77). The mean follow-up duration was 13.3 weeks (0.1-117.6). Overall median survival was 4.3 weeks (95% confidence interval, 2.2-6.4). The results from an analysis of clinical factors related to survival revealed that treatment modalities were significantly related to the patient's survival (log rank, p=0.006). Twenty patients (32.8%) experienced tumor bleeding, and the survival time of the patients with tumor bleeding tended to be shorter, although the result was not statistically significant (log rank, p=0.058). Hepatic reserve, by Child-Pugh classification, was grade A in 38 patients (64.4%), grade B in 16 patients (27.1%), and grade C in 5 patients (8.5%), and was significantly related to the patient's survival (log rank, p=0.000). CONCLUSION: Although patients with metastatic brain tumors from hepatocellular carcinoma showed poor survival, active intervention including surgical resection or gamma knife radiosurgery may result in better survival, especially if patients have preserved liver function.
format Online
Article
Text
id pubmed-4027101
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology
record_format MEDLINE/PubMed
spelling pubmed-40271012014-06-05 Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy Park, Tae Yong Na, Young Chul Lee, Won Hee Kim, Ji Hee Chang, Won Seok Jung, Hyun Ho Chang, Jong Hee Chang, Jin Woo Park, Young Gou Brain Tumor Res Treat Original Article OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamma knife radiosurgery or surgical intervention for these patients. METHODS: We retrospectively reviewed the medical records and imaging data of 59 patients with metastatic brain tumors from hepatocellular carcinoma from May 2004 to September 2012. The study included patients with available clinical and radiological data who had been diagnosed with metastatic hepatocellular carcinoma of the brain, confirmed by magnetic resonance imaging. The overall survival time was analyzed and compared according to each risk factor. RESULTS: The mean age at diagnosis of metastatic brain tumor was 52.2 years (14-77). The mean follow-up duration was 13.3 weeks (0.1-117.6). Overall median survival was 4.3 weeks (95% confidence interval, 2.2-6.4). The results from an analysis of clinical factors related to survival revealed that treatment modalities were significantly related to the patient's survival (log rank, p=0.006). Twenty patients (32.8%) experienced tumor bleeding, and the survival time of the patients with tumor bleeding tended to be shorter, although the result was not statistically significant (log rank, p=0.058). Hepatic reserve, by Child-Pugh classification, was grade A in 38 patients (64.4%), grade B in 16 patients (27.1%), and grade C in 5 patients (8.5%), and was significantly related to the patient's survival (log rank, p=0.000). CONCLUSION: Although patients with metastatic brain tumors from hepatocellular carcinoma showed poor survival, active intervention including surgical resection or gamma knife radiosurgery may result in better survival, especially if patients have preserved liver function. The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology 2013-10 2013-10-31 /pmc/articles/PMC4027101/ /pubmed/24904896 http://dx.doi.org/10.14791/btrt.2013.1.2.78 Text en Copyright © 2013 The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Tae Yong
Na, Young Chul
Lee, Won Hee
Kim, Ji Hee
Chang, Won Seok
Jung, Hyun Ho
Chang, Jong Hee
Chang, Jin Woo
Park, Young Gou
Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title_full Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title_fullStr Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title_full_unstemmed Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title_short Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
title_sort treatment options of metastatic brain tumors from hepatocellular carcinoma: surgical resection vs. gamma knife radiosurgery vs. whole brain radiation therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027101/
https://www.ncbi.nlm.nih.gov/pubmed/24904896
http://dx.doi.org/10.14791/btrt.2013.1.2.78
work_keys_str_mv AT parktaeyong treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT nayoungchul treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT leewonhee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT kimjihee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT changwonseok treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT junghyunho treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT changjonghee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT changjinwoo treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy
AT parkyounggou treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy